This year we initiated an Alzheimer’s prevention study to examine the potential to slow the onset and progression of the disease in people with early signs of the disease. Learn more about our approach and the importance of intervening with the right medicine at the right time.
The extent to which liraglutide, dulaglutide, semaglutide, and tirzepatide produce differential CNS penetration and GLP-1R target engagement has been partially studied in mice, but comparative human data using controlled PK & fMRI or PET is not available insight.jci.org/articles/view/…pic.twitter.com/v6RtslkD2s
This year we initiated an Alzheimer’s prevention study to examine the potential to slow the onset and progression of the disease in people with early signs of the disease. Learn more about our approach and the importance of intervening with the right medicine at the right time.